In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Aldeyra Therapeutics Inc’s stock clocked out at $6.31, down -8.68% from its previous closing price of $6.91. In other words, the price has decreased by -$8.68 from its previous closing price. On the day, 0.99 million shares were traded. ALDX stock price reached its highest trading level at $6.99 during the session, while it also had its lowest trading level at $6.16.
Ratios:
To gain a deeper understanding of ALDX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when Machatha Stephen sold 16,041 shares for $4.74 per share. The transaction valued at 75,975 led to the insider holds 236,771 shares of the business.
Greenberg Bruce sold 10,834 shares of ALDX for $51,313 on Aug 12 ’24. The insider now owns 126,382 shares after completing the transaction at $4.74 per share. On Aug 12 ’24, another insider, Greenberg Bruce, who serves as the Officer of the company, bought 10,834 shares for $5.10 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALDX now has a Market Capitalization of 376761888 and an Enterprise Value of 290913344.
Stock Price History:
The Beta on a monthly basis for ALDX is 0.83, which has changed by 1.214035 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, ALDX has reached a high of $7.20, while it has fallen to a 52-week low of $2.71. The 50-Day Moving Average of the stock is 8.85%, while the 200-Day Moving Average is calculated to be 25.71%.
Shares Statistics:
It appears that ALDX traded 465.75K shares on average per day over the past three months and 683100 shares per day over the past ten days. A total of 59.65M shares are outstanding, with a floating share count of 57.98M. Insiders hold about 2.90% of the company’s shares, while institutions hold 62.59% stake in the company. Shares short for ALDX as of 1740700800 were 3614145 with a Short Ratio of 7.76, compared to 1738281600 on 3670666. Therefore, it implies a Short% of Shares Outstanding of 3614145 and a Short% of Float of 7.28.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 5.0 analysts are dedicated to thoroughly evaluating and rating the performance of Aldeyra Therapeutics Inc (ALDX) in the stock market.The consensus estimate for the next quarter is $0.61, with high estimates of $2.48 and low estimates of -$0.26.
Analysts are recommending an EPS of between $1.52 and -$1.0 for the fiscal current year, implying an average EPS of -$0.27. EPS for the following year is -$0.47, with 5.0 analysts recommending between -$0.14 and -$0.68.
Revenue Estimates
Based on 6 analysts’ estimates, the company’s revenue will be $43.29M in the next fiscal year. The high estimate is $66.08M and the low estimate is $23M.
